Skip to main content
Erschienen in: Journal of Cancer Education 3/2015

01.09.2015

Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya

verfasst von: Joelle I. Rosser, Betty Njoroge, Megan J. Huchko

Erschienen in: Journal of Cancer Education | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Cervical cancer is a highly preventable disease that disproportionately affects women in developing countries and women with HIV. As integrated HIV and cervical cancer screening programs in Sub-Saharan Africa mature, we have an opportunity to measure the impact of outreach and education efforts and identify areas for future improvement. We conducted a cross-sectional survey of 106 women enrolled in care at an integrated HIV clinic in the Nyanza Province of Kenya 5 years after the start of a cervical cancer screening program. Female clinic attendees who met clinic criteria for cervical cancer screening were asked to complete an oral questionnaire assessing their cervical cancer knowledge, attitudes, and screening history. Ninety-nine percent of women had heard of screening, 70 % felt at risk, and 84 % had been screened. Increased duration of HIV diagnosis was associated with feeling at risk and with a screening history. Nearly half (48 %) of women said they would not get screened if they had to pay for it.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRefPubMed
2.
Zurück zum Zitat De Vuyst H, Ndirangu G, Moodley M et al (2012) Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer 131(4):949–955CrossRefPubMed De Vuyst H, Ndirangu G, Moodley M et al (2012) Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer 131(4):949–955CrossRefPubMed
4.
Zurück zum Zitat Louie KS, de Sanjose S, Mayaud P (2009) Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health 14(10):1287–1302CrossRefPubMed Louie KS, de Sanjose S, Mayaud P (2009) Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health 14(10):1287–1302CrossRefPubMed
5.
Zurück zum Zitat Gichangi P, De Vuyst H, Estambale B, Rogo K, Bwayo J, Temmerman M (2002) HIV and cervical cancer in Kenya. Int J Gynaecol Obstet 76(1):55–63CrossRefPubMed Gichangi P, De Vuyst H, Estambale B, Rogo K, Bwayo J, Temmerman M (2002) HIV and cervical cancer in Kenya. Int J Gynaecol Obstet 76(1):55–63CrossRefPubMed
6.
Zurück zum Zitat Belhadj H, Rasanathan JJ, Denny L, Broutet N (2013) Sexual and reproductive health and HIV services: integrating HIV/AIDS and cervical cancer prevention and control. Int J Gynaecol Obstet 121(Suppl 1):S29–S34CrossRefPubMed Belhadj H, Rasanathan JJ, Denny L, Broutet N (2013) Sexual and reproductive health and HIV services: integrating HIV/AIDS and cervical cancer prevention and control. Int J Gynaecol Obstet 121(Suppl 1):S29–S34CrossRefPubMed
7.
Zurück zum Zitat Memiah P, Mbuthia W, Kiiru G et al (2012) Prevalence and risk factors associated with precancerous cervical cancer lesions among HIV-infected women in resource-limited settings. AIDS Res Treat 2012:953743PubMedCentralPubMed Memiah P, Mbuthia W, Kiiru G et al (2012) Prevalence and risk factors associated with precancerous cervical cancer lesions among HIV-infected women in resource-limited settings. AIDS Res Treat 2012:953743PubMedCentralPubMed
8.
Zurück zum Zitat Huchko MJ, Bukusi EA, Cohen CR (2011) Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. Int J Gynaecol Obstet 114(2):106–110PubMedCentralCrossRefPubMed Huchko MJ, Bukusi EA, Cohen CR (2011) Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. Int J Gynaecol Obstet 114(2):106–110PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Kimanga DO, Ogola S, Umuro M, et al (2014) Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15–64 years in Kenya: results from a nationally representative study. J Acquir Immune Defic Syndr Kimanga DO, Ogola S, Umuro M, et al (2014) Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15–64 years in Kenya: results from a nationally representative study. J Acquir Immune Defic Syndr
11.
Zurück zum Zitat Francis SA, Nelson J, Liverpool J, Soogun S, Mofammere N, Thorpe RJ Jr (2010) Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine 28(50):8026–8032CrossRefPubMed Francis SA, Nelson J, Liverpool J, Soogun S, Mofammere N, Thorpe RJ Jr (2010) Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine 28(50):8026–8032CrossRefPubMed
12.
Zurück zum Zitat McFarland DM (2009) Beliefs about the causes of cervical cancer in Botswana: implications for nursing. Int Nurs Rev 56(4):426–432CrossRefPubMed McFarland DM (2009) Beliefs about the causes of cervical cancer in Botswana: implications for nursing. Int Nurs Rev 56(4):426–432CrossRefPubMed
13.
Zurück zum Zitat White HL, Mulambia C, Sinkala M et al (2012) ‘Worse than HIV’ or ‘not as serious as other diseases’? Conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med 74(10):1486–1493PubMedCentralCrossRefPubMed White HL, Mulambia C, Sinkala M et al (2012) ‘Worse than HIV’ or ‘not as serious as other diseases’? Conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med 74(10):1486–1493PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Maree JE, Wright SC (2011) Cervical cancer: does our message promote screening? A pilot study in a South African context. Eur J Oncol Nurs 15(2):118–123CrossRefPubMed Maree JE, Wright SC (2011) Cervical cancer: does our message promote screening? A pilot study in a South African context. Eur J Oncol Nurs 15(2):118–123CrossRefPubMed
15.
Zurück zum Zitat Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR (2011) HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav 15(6):1111–1120PubMedCentralCrossRefPubMed Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR (2011) HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav 15(6):1111–1120PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Rosser JI, Njoroge B, Huchko MJ (2014) Knowledge about cervical cancer screening and perception of risk among women attending outpatient clinics in rural Kenya. Int J Gynaecol Obstet Rosser JI, Njoroge B, Huchko MJ (2014) Knowledge about cervical cancer screening and perception of risk among women attending outpatient clinics in rural Kenya. Int J Gynaecol Obstet
Metadaten
Titel
Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya
verfasst von
Joelle I. Rosser
Betty Njoroge
Megan J. Huchko
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 3/2015
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0787-7

Weitere Artikel der Ausgabe 3/2015

Journal of Cancer Education 3/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.